These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1407599)

  • 41. [Baclofen dose in a screening test and in a baclofen pump filling--is there any differences].
    Grzegorzewski P; Kawecki Z; Swierczyńska A; Fafara A; Kwiatkowski S
    Przegl Lek; 2007; 64 Suppl 2():8-12. PubMed ID: 17953271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of intrathecally administered baclofen on function in patients with spasticity.
    Campbell SK; Almeida GL; Penn RD; Corcos DM
    Phys Ther; 1995 May; 75(5):352-62. PubMed ID: 7732079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional outcome after delivery of intrathecal baclofen.
    Parke B; Penn RD; Savoy SM; Corcos D
    Arch Phys Med Rehabil; 1989 Jan; 70(1):30-2. PubMed ID: 2916915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hyperthermia associated with baclofen withdrawal and increased spasticity.
    Mandac BR; Hurvitz EA; Nelson VS
    Arch Phys Med Rehabil; 1993 Jan; 74(1):96-7. PubMed ID: 8420527
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity.
    Hassan N; McLellan DL
    J Neurol Neurosurg Psychiatry; 1980 Dec; 43(12):1132-6. PubMed ID: 7217960
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The incidence and management of tolerance in intrathecal baclofen therapy.
    Heetla HW; Staal MJ; Kliphuis C; van Laar T
    Spinal Cord; 2009 Oct; 47(10):751-6. PubMed ID: 19333246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous intrathecal baclofen infusion for spasticity of cerebral origin.
    Albright AL; Barron WB; Fasick MP; Polinko P; Janosky J
    JAMA; 1993 Nov; 270(20):2475-7. PubMed ID: 8230625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term intrathecal baclofen therapy for severe spasticity of cerebral origin.
    Albright AL; Gilmartin R; Swift D; Krach LE; Ivanhoe CB; McLaughlin JF
    J Neurosurg; 2003 Feb; 98(2):291-5. PubMed ID: 12593613
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrathecal baclofen.
    Ochs GA
    Baillieres Clin Neurol; 1993 Apr; 2(1):73-86. PubMed ID: 8143075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Usefulness of Bolus Administration Using the FLEX Mode(Bolus Infusion Mode)for Baclofen Tolerance].
    Tanaka K
    No Shinkei Geka; 2017 Feb; 45(2):133-137. PubMed ID: 28202830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Continuous intrathecal infusion of baclofen. A new therapeutic method for spasticity].
    Berg-Johnsen J; Røste GK; Solgaard T; Lundar T
    Tidsskr Nor Laegeforen; 1998 Sep; 118(21):3256-60. PubMed ID: 9772811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intrathecal baclofen in multiple sclerosis: too little, too late?
    Erwin A; Gudesblatt M; Bethoux F; Bennett SE; Koelbel S; Plunkett R; Sadiq S; Stevenson VL; Thomas AM; Tornatore C; Zaffaroni M; Hughes M
    Mult Scler; 2011 May; 17(5):623-9. PubMed ID: 21282321
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy in a quadriplegic patient treated with continuous intrathecal baclofen infusion to manage her severe spasticity. Case report.
    Delhaas EM; Verhagen J
    Paraplegia; 1992 Jul; 30(7):527-8. PubMed ID: 1508570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system.
    Postma TJ; Oenema D; Terpstra S; Bouma J; Kuipers-Upmeijer H; Staal MJ; Middel BJ
    Pharmacoeconomics; 1999 Apr; 15(4):395-404. PubMed ID: 10537958
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety of oral baclofen in the management of spasticity: A rationale for intrathecal baclofen.
    Ertzgaard P; Campo C; Calabrese A
    J Rehabil Med; 2017 Mar; 49(3):193-203. PubMed ID: 28233010
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Occurrence of adverse events in long-term intrathecal baclofen infusion: a 1-year follow-up study of 158 adults.
    Borrini L; Bensmail D; Thiebaut JB; Hugeron C; Rech C; Jourdan C
    Arch Phys Med Rehabil; 2014 Jun; 95(6):1032-8. PubMed ID: 24407102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis.
    Marquardt G; Seifert V
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):275-6. PubMed ID: 11796788
    [No Abstract]   [Full Text] [Related]  

  • 58. Prolonged seizure activity after baclofen withdrawal.
    Kofler M; Arturo Leis A
    Neurology; 1992 Mar; 42(3 Pt 1):697-8. PubMed ID: 1549245
    [No Abstract]   [Full Text] [Related]  

  • 59. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study.
    Coffey JR; Cahill D; Steers W; Park TS; Ordia J; Meythaler J; Herman R; Shetter AG; Levy R; Gill B
    J Neurosurg; 1993 Feb; 78(2):226-32. PubMed ID: 8421205
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intrathecal baclofen pump implantation during pregnancy.
    Roberts AG; Graves CR; Konrad PE; Groomes TE; Pfister AA; Damian MM; Charles PD
    Neurology; 2003 Oct; 61(8):1156-7. PubMed ID: 14581694
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.